2Tsushima N ,Matsuo H,Nakajima N,et al. Present status and long-term prognosis of patients with arterioscerosis obliter ans in Japan. Prog Cardiovasc Dis ,1991,12:26.
3Paolo R,Falvio F,Biagio DS,et al. Diabetes mellitus and localizations of obliterating arterial disease of the lower limbs.Angiology,1991,12: 296.
5Goncalves LM, Epstein SE, Piek JJ. Controlling collateral development: the difficult task of mimicking mother nature. Cardiovasc Res, 2001,49:495-496.
6Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol, 1999,154:355-363.
7Simovic D, Isner JM, Ropper AH, ct al. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol, 2001,58:761-768.
8Napoli C, Williarns-Ignarro S, Nigris F, et al. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.PNAS, 2005,102 : 17202-17206.
9Kinnaird T, Stabile E, Bumett MS, et al. Bone marrow-derlved cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res, 2004,95:354-363.
10Waltenberger J. Impaired collateral vessel development in diabetes:potential cellular mechanisms and therapeutic implications. Cardiovasc Res, 2001,49:554-560.
